Sign inJoin waitlistJoin the waitlist

Andrew Ip

Associate Program Director · Hackensack Meridian Health

Credentials: · · · · · ·

History

Hackensack Meridian Health
Present
Hackensack Meridian Health
Present

Hematology and Medical Oncology
Emory University School of Medicine
2016–2019
Internal Medicine
Emory University School of Medicine
2012–2015
Sidney Kimmel Medical College at Thomas Jefferson University
2008–2012

Research

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
The Lancet Rheumatology · 2020 · 207 citations
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
PLoS ONE · 2020 · First of 32 authors · 98 citations
PI3K Inhibitors: Understanding Toxicity Mechanisms and Management
Review · Oncology · 2017 · 96 citations

Andre Goy
25 papers
Lori Leslie
17 papers
Andrew Pecora
15 papers
RS
Roni Shouval
12 papers · 8 as a fellow
Gunjan Shah
11 papers
Lia Palomba
11 papers
MA
Maher Albitar
11 papers
Michael Scordo
11 papers
MP
Miguel-Angel Perales
11 papers
GS
Gilles Salles
10 papers
Tatyana Feldman
10 papers
David Siegel
8 papers

Clinical trials

A Prospective "Universal" Observational Database for COVID-19
Principal investigator · Completed
Hackensack Meridian Health
2020–2023
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Site PI · Recruiting · Phase 3
Ono Pharmaceutical Co., Ltd.
2026–2029